What is Establishment Labs Hldgs Inc's earnings per share (EPS)?

Establishment Labs Hldgs Inc (ESTA) reported diluted earnings per share of $-1.72 for fiscal year 2025. This represents a 42.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Establishment Labs Hldgs Inc Financials

ESTA

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Establishment Labs Hldgs Inc (ESTA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 23/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Establishment Labs Hldgs Inc has an operating margin of -18.5%, meaning the company retains $-18 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -30.1% the prior year.

Growth

Establishment Labs Hldgs Inc's revenue surged 27.1% year-over-year to $211.1M, reflecting rapid business expansion. This strong growth earns a score of 79/100.

Leverage

Establishment Labs Hldgs Inc has elevated debt relative to equity (D/E of 10.51), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity

Establishment Labs Hldgs Inc's current ratio of 3.04 indicates adequate short-term liquidity, earning a score of 58/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

While Establishment Labs Hldgs Inc generated -$50.9M in operating cash flow, capex of $6.0M consumed most of it, leaving -$56.9M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Establishment Labs Hldgs Inc generates a -216.9% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -159.3% the prior year.

Piotroski F-Score Neutral

4/9

Establishment Labs Hldgs Inc passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Low Quality

1.00x

For every $1 of reported earnings, Establishment Labs Hldgs Inc generates $1.00 in operating cash flow (-$50.9M OCF vs -$51.1M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-1.5x

Establishment Labs Hldgs Inc earns $-1.5 in operating income for every $1 of interest expense (-$39.0M vs $25.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$211.1M

YoY+27.1%

5Y CAGR+20.0%

Establishment Labs Hldgs Inc generated $211.1M in revenue in fiscal year 2025. This represents an increase of 27.1% from the prior year.

EBITDA

-$32.8M

YoY+27.6%

Establishment Labs Hldgs Inc's EBITDA was -$32.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 27.6% from the prior year.

Net Income

-$51.1M

YoY+39.6%

Establishment Labs Hldgs Inc reported -$51.1M in net income in fiscal year 2025. This represents an increase of 39.6% from the prior year.

EPS (Diluted)

$-1.72

YoY+42.7%

Establishment Labs Hldgs Inc earned $-1.72 per diluted share (EPS) in fiscal year 2025. This represents an increase of 42.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$56.9M

YoY+11.9%

Establishment Labs Hldgs Inc generated -$56.9M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 11.9% from the prior year.

Cash & Debt

$75.6M

YoY-16.4%

5Y CAGR-2.2%

Establishment Labs Hldgs Inc held $75.6M in cash against $247.5M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

29M

YoY+1.8%

5Y CAGR+4.5%

Establishment Labs Hldgs Inc had 29M shares outstanding in fiscal year 2025. This represents an increase of 1.8% from the prior year.

Margins & Returns

Gross Margin

69.3%

YoY+3.4pp

5Y CAGR+7.3pp

Establishment Labs Hldgs Inc's gross margin was 69.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 3.4 percentage points from the prior year.

Operating Margin

-18.5%

YoY+11.6pp

5Y CAGR+14.5pp

Establishment Labs Hldgs Inc's operating margin was -18.5% in fiscal year 2025, reflecting core business profitability. This is up 11.6 percentage points from the prior year.

Net Margin

-24.2%

YoY+26.8pp

5Y CAGR+20.8pp

Establishment Labs Hldgs Inc's net profit margin was -24.2% in fiscal year 2025, showing the share of revenue converted to profit. This is up 26.8 percentage points from the prior year.

Return on Equity

-216.9%

YoY-57.5pp

5Y CAGR-166.0pp

Establishment Labs Hldgs Inc's ROE was -216.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 57.5 percentage points from the prior year.

Capital Allocation

R&D Spending

$20.2M

YoY+2.7%

5Y CAGR+8.0%

Establishment Labs Hldgs Inc invested $20.2M in research and development in fiscal year 2025. This represents an increase of 2.7% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$6.0M

YoY-1.1%

5Y CAGR+23.5%

Establishment Labs Hldgs Inc invested $6.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 1.1% from the prior year.

ESTA Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$211.1M+27.1%	$166.0M+0.5%	$165.2M+2.1%	$161.7M+27.6%	$126.7M+49.6%	$84.7M
Cost of Revenue	$64.8M+14.6%	$56.5M-2.9%	$58.2M+5.6%	$55.1M+33.5%	$41.3M+28.3%	$32.2M
Gross Profit	$146.3M+33.6%	$109.5M+2.4%	$107.0M+0.4%	$106.6M+24.8%	$85.4M+62.7%	$52.5M
R&D Expenses	$20.2M+2.7%	$19.7M-25.4%	$26.4M+30.4%	$20.3M+10.7%	$18.3M+32.8%	$13.8M
SG&A Expenses	$165.1M+18.1%	$139.8M-4.0%	$145.6M+15.6%	$126.0M+36.6%	$92.2M+38.4%	$66.6M
Operating Income	-$39.0M+22.0%	-$50.0M+23.1%	-$65.0M-64.0%	-$39.7M-57.7%	-$25.1M+9.9%	-$27.9M
Interest Expense	$25.3M+21.3%	$20.8M+35.3%	$15.4M+30.9%	$11.8M+29.8%	$9.1M-3.3%	$9.4M
Income Tax	-$7.0M-21643.8%	-$32K+60.5%	-$81K-103.4%	$2.4M+67.1%	$1.4M+1272.1%	$104K
Net Income	-$51.1M+39.6%	-$84.6M-7.8%	-$78.5M-4.4%	-$75.2M-82.8%	-$41.1M-7.9%	-$38.1M
EPS (Diluted)	$-1.72+42.7%	$-3.00+2.3%	$-3.07+0.3%	$-3.08-79.1%	$-1.72-5.5%	$-1.63

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$64.6M+20.1%	$53.8M+4.8%	$51.3M+24.0%	$41.4M-7.0%	$44.5M+10.7%	$40.2M-8.8%	$44.1M+18.7%	$37.2M
Cost of Revenue	$19.1M+18.6%	$16.1M+0.4%	$16.0M+18.1%	$13.6M-3.2%	$14.0M-3.4%	$14.5M-4.4%	$15.2M+18.7%	$12.8M
Gross Profit	$45.5M+20.8%	$37.7M+6.9%	$35.3M+26.8%	$27.8M-8.8%	$30.5M+18.6%	$25.7M-11.1%	$28.9M+18.7%	$24.4M
R&D Expenses	$5.4M+19.3%	$4.6M-12.5%	$5.2M+2.9%	$5.1M-1.7%	$5.1M+7.1%	$4.8M-12.5%	$5.5M+28.4%	$4.3M
SG&A Expenses	$44.0M+18.5%	$37.2M-15.9%	$44.2M+11.3%	$39.7M-9.8%	$44.0M+29.3%	$34.1M+3.9%	$32.8M+13.3%	$28.9M
Operating Income	-$3.9M+2.4%	-$4.0M+71.5%	-$14.1M+16.8%	-$16.9M+9.2%	-$18.7M-42.1%	-$13.1M-40.6%	-$9.3M-5.8%	-$8.8M
Interest Expense	$7.2M+16.8%	$6.2M+4.1%	$6.0M+1.8%	$5.9M-1.6%	$5.9M+12.0%	$5.3M+2.4%	$5.2M+18.4%	$4.4M
Income Tax	-$9.3M-2293.4%	$424K-57.8%	$1.0M+9.8%	$914K+164.9%	-$1.4M-376.1%	$510K+19.2%	$428K-2.3%	$438K
Net Income	-$2.6M+76.5%	-$11.1M+32.8%	-$16.6M+19.9%	-$20.7M+40.0%	-$34.5M-107.0%	-$16.7M+2.9%	-$17.2M-6.0%	-$16.2M
EPS (Diluted)	N/A	$-0.38+33.3%	$-0.57+18.6%	$-0.70	N/A	$-0.59+4.8%	$-0.62-6.9%	$-0.58

ESTA Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$357.2M+3.0%	$346.8M+29.1%	$268.6M+27.3%	$211.1M+51.3%	$139.5M-10.8%	$156.4M
Current Assets	$249.9M+2.8%	$243.0M+39.0%	$174.9M+16.7%	$149.9M+32.3%	$113.3M-14.4%	$132.3M
Cash & Equivalents	$75.6M-16.4%	$90.3M+125.7%	$40.0M-39.7%	$66.4M+24.2%	$53.4M-36.8%	$84.5M
Inventory	$85.6M+8.7%	$78.8M-0.9%	$79.5M+117.2%	$36.6M+28.8%	$28.4M+22.4%	$23.2M
Accounts Receivable	$77.5M+19.2%	$65.0M+38.5%	$46.9M+32.5%	$35.4M+45.0%	$24.4M+27.8%	$19.1M
Goodwill	$1.2M0.0%	$1.2M+160.0%	$465K0.0%	$465K0.0%	$465K0.0%	$465K
Total Liabilities	$333.6M+13.6%	$293.7M+17.4%	$250.2M+14.1%	$219.2M+146.9%	$88.8M+9.0%	$81.4M
Current Liabilities	$82.1M+20.3%	$68.3M+19.5%	$57.1M+46.7%	$39.0M+22.2%	$31.9M+23.1%	$25.9M
Long-Term Debt	$247.5M+12.7%	$219.6M+16.3%	$188.7M+7.6%	$175.5M+238.0%	$51.9M+4.2%	$49.8M
Total Equity	$23.5M-55.7%	$53.1M+188.6%	$18.4M+324.7%	-$8.2M-116.1%	$50.7M-32.3%	$75.0M
Retained Earnings	-$495.8M-11.5%	-$444.7M-23.5%	-$360.1M-27.9%	-$281.6M-36.4%	-$206.4M-24.9%	-$165.2M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$357.2M+5.4%	$338.9M+2.8%	$329.7M-1.1%	$333.4M-3.9%	$346.8M+22.7%	$282.7M-0.8%	$285.1M-5.5%	$301.8M
Current Assets	$249.9M+4.3%	$239.6M+4.6%	$229.2M-1.1%	$231.7M-4.7%	$243.0M+32.8%	$183.0M-1.7%	$186.1M-8.6%	$203.7M
Cash & Equivalents	$75.6M+7.0%	$70.6M+29.3%	$54.6M-21.0%	$69.2M-23.4%	$90.3M+127.6%	$39.7M-27.3%	$54.6M-25.2%	$73.0M
Inventory	$85.6M-2.9%	$88.2M-6.9%	$94.7M+4.7%	$90.4M+14.8%	$78.8M+17.3%	$67.1M+4.5%	$64.2M-11.4%	$72.5M
Accounts Receivable	$77.5M+8.5%	$71.4M+1.9%	$70.1M+10.8%	$63.2M-2.7%	$65.0M-3.3%	$67.3M+12.1%	$60.0M+18.0%	$50.8M
Goodwill	$1.2M0.0%	$1.2M0.0%	$1.2M0.0%	$1.2M0.0%	$1.2M+160.0%	$465K0.0%	$465K0.0%	$465K
Total Liabilities	$333.6M+3.4%	$322.5M+5.1%	$306.9M+4.1%	$294.8M+0.4%	$293.7M+17.5%	$250.0M+4.1%	$240.1M-2.0%	$244.9M
Current Liabilities	$82.1M+14.1%	$72.0M-10.9%	$80.7M+17.0%	$69.0M+1.1%	$68.3M+35.2%	$50.5M+20.5%	$41.9M-12.8%	$48.0M
Long-Term Debt	$247.5M+0.4%	$246.5M+11.5%	$221.1M+0.4%	$220.3M+0.3%	$219.6M+13.0%	$194.4M+0.3%	$193.7M+0.8%	$192.2M
Total Equity	$23.5M+43.9%	$16.4M-28.1%	$22.8M-41.0%	$38.5M-27.4%	$53.1M+62.3%	$32.7M-27.3%	$45.0M-20.9%	$56.9M
Retained Earnings	-$495.8M-0.5%	-$493.1M-2.3%	-$482.0M-3.6%	-$465.4M-4.7%	-$444.7M-8.4%	-$410.2M-4.2%	-$393.5M-4.6%	-$376.3M

ESTA Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$50.9M+13.0%	-$58.5M+33.9%	-$88.5M-69.7%	-$52.2M-89.5%	-$27.5M-120.1%	-$12.5M
Capital Expenditures	$6.0M-1.1%	$6.1M-22.7%	$7.9M+177.4%	$2.9M+17.6%	$2.4M+15.1%	$2.1M
Free Cash Flow	-$56.9M+11.9%	-$64.6M+33.0%	-$96.4M-75.3%	-$55.0M-83.7%	-$30.0M-105.0%	-$14.6M
Investing Cash Flow	-$7.0M+55.0%	-$15.6M+36.4%	-$24.5M+29.4%	-$34.8M-385.7%	-$7.2M-28.9%	-$5.6M
Financing Cash Flow	$40.4M-67.9%	$125.9M+46.0%	$86.2M-14.0%	$100.3M+2374.2%	$4.1M-93.7%	$64.7M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	-$162K+98.6%	-$11.3M+40.0%	-$18.8M+9.5%	-$20.7M+0.1%	-$20.7M-66.5%	-$12.5M+12.0%	-$14.2M-26.9%	-$11.2M
Capital Expenditures	$1.8M-1.3%	$1.8M+13.8%	$1.6M+115.7%	$753K+41.8%	$531K-64.0%	$1.5M+84.6%	$798K-75.9%	$3.3M
Free Cash Flow	-$2.0M+84.8%	-$13.1M+35.7%	-$20.4M+5.1%	-$21.5M-0.9%	-$21.3M-52.7%	-$13.9M+6.8%	-$15.0M-3.4%	-$14.5M
Investing Cash Flow	-$1.7M+15.3%	-$2.0M+5.4%	-$2.1M-55.0%	-$1.3M+26.6%	-$1.8M+34.2%	-$2.8M+37.2%	-$4.4M+33.6%	-$6.6M
Financing Cash Flow	$6.1M-79.4%	$29.5M+474.3%	$5.1M+2626.6%	-$203K-100.3%	$74.5M+266139.3%	-$28K-107.2%	$389K-99.2%	$51.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

ESTA Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	69.3%+3.4pp	66.0%+1.2pp	64.8%-1.1pp	65.9%-1.5pp	67.4%+5.4pp	62.0%
Operating Margin	-18.5%+11.6pp	-30.1%+9.3pp	-39.4%-14.8pp	-24.5%-4.7pp	-19.8%+13.1pp	-33.0%
Net Margin	-24.2%+26.8pp	-50.9%-3.4pp	-47.5%-1.0pp	-46.5%-14.0pp	-32.5%+12.6pp	-45.0%
Return on Equity	-216.9%-57.5pp	-159.3%+267.4pp	-426.8%	N/A	-81.1%-30.2pp	-50.8%
Return on Assets	-14.3%+10.1pp	-24.4%+4.8pp	-29.2%+6.4pp	-35.6%-6.2pp	-29.5%-5.1pp	-24.4%
Current Ratio	3.04-0.5	3.56+0.5	3.06-0.8	3.85+0.3	3.55-1.6	5.11
Debt-to-Equity	10.51+6.4	4.14-6.1	10.26+31.7	-21.44-22.5	1.02+0.4	0.66
FCF Margin	-27.0%+11.9pp	-38.9%+19.4pp	-58.4%-24.4pp	-34.0%-10.4pp	-23.6%-6.4pp	-17.3%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	70.5%+0.4pp	70.1%+1.3pp	68.8%+1.5pp	67.2%-1.3pp	68.5%+4.6pp	63.9%-1.7pp	65.6%0.0pp	65.6%
Operating Margin	-6.1%+1.4pp	-7.5%+20.0pp	-27.5%+13.5pp	-41.0%+1.0pp	-41.9%-9.3pp	-32.7%-11.5pp	-21.2%+2.6pp	-23.8%
Net Margin	-4.0%+16.7pp	-20.7%+11.6pp	-32.4%+17.7pp	-50.0%+27.5pp	-77.6%-36.1pp	-41.5%-2.5pp	-38.9%+4.6pp	-43.6%
Return on Equity	-11.1%+57.0pp	-68.1%+4.8pp	-72.9%-19.2pp	-53.7%+11.3pp	-65.0%-14.0pp	-51.0%-12.8pp	-38.2%-9.7pp	-28.5%
Return on Assets	-0.7%+2.6pp	-3.3%+1.7pp	-5.0%+1.2pp	-6.2%+3.7pp	-10.0%-4.1pp	-5.9%+0.1pp	-6.0%-0.7pp	-5.4%
Current Ratio	3.04-0.3	3.33+0.5	2.84-0.5	3.36-0.2	3.56-0.1	3.62-0.8	4.44+0.2	4.24
Debt-to-Equity	10.51-4.6	15.06+5.3	9.71+4.0	5.72+1.6	4.14-1.8	5.94+1.6	4.30+0.9	3.38
FCF Margin	-3.1%+21.3pp	-24.3%+15.4pp	-39.7%+12.2pp	-51.9%-4.1pp	-47.8%-13.2pp	-34.6%-0.8pp	-33.9%+5.0pp	-38.9%

Similar Companies

Integra Lifesciences Hldgs Cp IART

$742.7M

SS Innovations SSII

$1.0B

Iradimed Corp IRMD

$1.2B

Beta Bionics, Inc. BBNX

$440.7M

Inmode Ltd. INMD

$873.7M

Frequently Asked Questions

What is Establishment Labs Hldgs Inc's annual revenue?

Establishment Labs Hldgs Inc (ESTA) reported $211.1M in total revenue for fiscal year 2025. This represents a 27.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Establishment Labs Hldgs Inc's revenue growing?

Establishment Labs Hldgs Inc (ESTA) revenue grew by 27.1% year-over-year, from $166.0M to $211.1M in fiscal year 2025.

Is Establishment Labs Hldgs Inc profitable?

No, Establishment Labs Hldgs Inc (ESTA) reported a net income of -$51.1M in fiscal year 2025, with a net profit margin of -24.2%.

What is Establishment Labs Hldgs Inc's EBITDA?

Establishment Labs Hldgs Inc (ESTA) had EBITDA of -$32.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Establishment Labs Hldgs Inc have?

As of fiscal year 2025, Establishment Labs Hldgs Inc (ESTA) had $75.6M in cash and equivalents against $247.5M in long-term debt.

What is Establishment Labs Hldgs Inc's gross margin?

Establishment Labs Hldgs Inc (ESTA) had a gross margin of 69.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Establishment Labs Hldgs Inc's operating margin?

Establishment Labs Hldgs Inc (ESTA) had an operating margin of -18.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Establishment Labs Hldgs Inc's net profit margin?

Establishment Labs Hldgs Inc (ESTA) had a net profit margin of -24.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Establishment Labs Hldgs Inc's return on equity (ROE)?

Establishment Labs Hldgs Inc (ESTA) has a return on equity of -216.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Establishment Labs Hldgs Inc's free cash flow?

Establishment Labs Hldgs Inc (ESTA) generated -$56.9M in free cash flow during fiscal year 2025. This represents a 11.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Establishment Labs Hldgs Inc's operating cash flow?

Establishment Labs Hldgs Inc (ESTA) generated -$50.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Establishment Labs Hldgs Inc's total assets?

Establishment Labs Hldgs Inc (ESTA) had $357.2M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Establishment Labs Hldgs Inc's capital expenditures?

Establishment Labs Hldgs Inc (ESTA) invested $6.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Establishment Labs Hldgs Inc spend on research and development?

Establishment Labs Hldgs Inc (ESTA) invested $20.2M in research and development during fiscal year 2025.

How many shares does Establishment Labs Hldgs Inc have outstanding?

Establishment Labs Hldgs Inc (ESTA) had 29M shares outstanding as of fiscal year 2025.

What is Establishment Labs Hldgs Inc's current ratio?

Establishment Labs Hldgs Inc (ESTA) had a current ratio of 3.04 as of fiscal year 2025, which is generally considered healthy.

What is Establishment Labs Hldgs Inc's debt-to-equity ratio?

Establishment Labs Hldgs Inc (ESTA) had a debt-to-equity ratio of 10.51 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Establishment Labs Hldgs Inc's return on assets (ROA)?

Establishment Labs Hldgs Inc (ESTA) had a return on assets of -14.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Establishment Labs Hldgs Inc's cash runway?

Based on fiscal year 2025 data, Establishment Labs Hldgs Inc (ESTA) had $75.6M in cash against an annual operating cash burn of $50.9M. This gives an estimated cash runway of approximately 18 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Establishment Labs Hldgs Inc's Piotroski F-Score?

Establishment Labs Hldgs Inc (ESTA) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Establishment Labs Hldgs Inc's earnings high quality?

Establishment Labs Hldgs Inc (ESTA) has an earnings quality ratio of 1.00x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Establishment Labs Hldgs Inc cover its interest payments?

Establishment Labs Hldgs Inc (ESTA) has an interest coverage ratio of -1.5x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Establishment Labs Hldgs Inc?

Establishment Labs Hldgs Inc (ESTA) scores 23 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.